FIELD: molecular biology, veterinary science. SUBSTANCE: invention relates to field of vaccination and diagnosis of K.P.C. diseases caused by pathogenic bacteria, in part, to living attenuated and inactivated vaccines for protection of animals against herpes virus type-I. Vaccine is developed on the base of mutant herpes virus BHV-I having deletion in gene gE encoding glycoproteid with gene having the corresponding location in BHV-I genome being indicated deletion ensures to distinct this mutant serologically from BHV-I of wild type. Invention relates to also diagnostic sets for detection of BHV-I nucleic acid, antibodies showing specificity to BHV-I, BHV-I protein and method of detection of BHV-I infection in animals. EFFECT: enhanced effectiveness and safety of developed preparation and method. 6 cl, 29 dwg, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
MUTANT GP 50 FOR VECTOR VACCINE PREPARING, VECTOR VACCINE ANDMUTANT GP 50 FOR VECTOR VACCINE PREPARING, VECTOR VACCINE AND METHOD OF ITS PRODUCING | 1993 |
|
RU2158308C2 |
NUCLEOTIDE SEQUENCE OF CLASSIC SWINE FEVER VIRUS (CSFV) (VARIANTS), POLYPEPTIDE CSFV, PESTOVIRAL VACCINE AGAINST CSFV, DIAGNOSTIC SET AND METHOD | 1995 |
|
RU2201451C2 |
COMPOSITION BASED ON LELISTAD FACTOR (VARIANTS), VACCINE (VARIANTS), DIAGNOSTIC SET (VARIANTS) AND METHOD OF DIAGNOSIS | 1992 |
|
RU2124051C1 |
VACCINE FORMULA AGAINST BOVINE RESPIRATORY PATHOLOGIES | 2002 |
|
RU2305560C2 |
METHOD OF OBTAINING CONTINUOUS CELL LINE AND APPLICATION OF CONTINUOUS CELL LINE | 2003 |
|
RU2329060C2 |
RECOMBINANT HVT-VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND VACCINES CONTAINING THESE VECTORS | 2017 |
|
RU2752836C2 |
FUSED POLYPEPTIDES AND VACCINES | 2014 |
|
RU2699006C2 |
LIVE ATTENUATED VACCINES | 2010 |
|
RU2556813C2 |
MUTANT HERPES VIRUS-COMPRISING VACCINE | 1991 |
|
RU2236256C2 |
METHOD OF PREPARING AN ATTENUATED STRAIN OF BACTERIUM SALMONELLA AND A VACCINE | 1992 |
|
RU2126447C1 |
Authors
Dates
2001-07-10—Published
1992-06-05—Filed